variables: 816995
Data license: CC-BY
This data as json
id | name | unit | description | createdAt | updatedAt | code | coverage | timespan | datasetId | sourceId | shortUnit | display | columnOrder | originalMetadata | grapherConfigAdmin | shortName | catalogPath | dimensions | schemaVersion | processingLevel | processingLog | titlePublic | titleVariant | attributionShort | attribution | descriptionShort | descriptionFromProducer | descriptionKey | descriptionProcessing | licenses | license | grapherConfigETL | type | sort | dataChecksum | metadataChecksum |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
816995 | Previously treated bacteriologically confirmed pulmonary tuberculosis cases with isoniazid resistance | previously treated cases with isoniazid resistance | 2023-12-05 11:52:00 | 2024-07-25 22:54:11 | 2017-2022 | 6308 | { "unit": "previously treated cases with isoniazid resistance", "numDecimalPlaces": 0 } |
0 | dst_rlt_hr_ret | grapher/tuberculosis/2023-11-27/drug_resistance_surveillance/drug_resistance_surveillance#dst_rlt_hr_ret | 2 | major | Number of previously treated bacteriologically confirmed pulmonary tuberculosis cases tested for isoniazid and rifampicin resistance with isoniazid resistance. Isoniazid and rifampicin are antibiotics used to treat tuberculosis. | Number of previously treated bacteriologically confirmed pulmonary tuberculosis patients with test results for rifampicin and isoniazid and with resistance to isoniazid (regardless of result for rifampicin). | [] |
int | [] |
20fd44b90896f2f2ac073043e875db5e | 1236a20d05c26078ba32442ecd79430b |